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ABSTRACT
Objective: The study sought to develop an in-depth understanding of how hospitals with a long history of health
information technology (HIT) use have responded to the COVID-19 (coronavirus disease 2019) pandemic from
an HIT perspective.
Materials and Methods: We undertook interviews with 44 healthcare professionals with a background in infor-
matics from 6 hospitals internationally. Interviews were informed by a topic guide and were conducted via vid-
eoconferencing software. Thematic analysis was employed to develop a coding framework and identify emerg-
ing themes.
Results: Three themes and 6 subthemes were identified. HITs were employed to manage time and resources
during a surge in patient numbers through fast-tracked governance procedures, and the creation of real-time
bed capacity tracking within electronic health records. Improving the integration of different hospital systems
was identified as important across sites. The use of hard-stop alerts and order sets were perceived as being ef-
fective at helping to respond to potential medication shortages and selecting available drug treatments. Utiliz-
ing information from multiple data sources to develop alerts facilitated treatment. Finally, the upscaling/optimi-
zation of telehealth and remote working capabilities was used to reduce the risk of nosocomial infection within
hospitals.
Discussion: A number of the HIT-related changes implemented at these sites were perceived to have facilitated
more effective patient treatment and management of resources. Informaticians generally felt more valued by
hospital management as a result.
Conclusions: Improving integration between data systems, utilizing specialized alerts, and expanding telehealth
represent strategies that hospitals should consider when using HIT for delivering hospital care in the context of
the COVID-19 pandemic.
Key words: electronic health records, medical informatics, patient safety, quality of health care, telemedicine
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The novel coronavirus disease 2019 (COVID-19), which causes se-
vere respiratory disease in high-risk groups,1 was first identified in
Wuhan in China and has subsequently progressed to a global pan-
demic causing over 100 million infections and almost 2.3 million
deaths as of February 2021.2 Despite unprecedented measures to
control the spread of the virus,3 prevalence remains high, and health
services have been under considerable strain as a result.4–7 For ex-
ample, one meta-analysis found that 32% of patients entering hospi-
tal due to COVID-19 were subsequently admitted to intensive care
units (ICUs).8 Additionally, hospitals have experienced significant
increased strain due to drug shortages,5 ICU resource shortages,9
and infection of frontline healthcare personnel.4
While long-term solutions to the pandemic will likely be based
on the rollout of vaccines and effective treatments,10,11 a number of
researchers and practitioners have highlighted the role that elec-
tronic health records (EHRs), computerized physician order entry
(CPOE) systems, and telehealth can play in managing and treating
the high volume of hospital admissions and cases effectively,12–16
which is typically managed by medical informaticians. Such technol-
ogies have already been successfully utilized to manage patients dur-
ing the ongoing COVID-19 pandemic. For example, reports and
studies have advocated for the role telehealth could play in reducing
risk of both provider and routine patient exposure to the virus.17–21
Additionally, using data from EHRs to identify potential cases and
manage workflow has been highlighted as a potential strategy, as
has the customization of provider screens, clinical decision support
(CDS), and efforts to increase interoperability of different systems
within the wider EHR.13,14,22
Objectives
Health systems in economically developed countries have seen in-
creased uptake of EHR implementation and related health informa-
tion technology (HIT) in recent years.23,24 However, identifying
approaches to appropriately and effectively use such technology to
combat the burden of COVID-19 requires knowledge sharing.
Therefore, the aim of this qualitative study was to identify HIT
strategies used by digitally mature hospitals in direct response to
COVID-19 and make recommendations based on these approaches.
MATERIALS AND METHODS
This article forms part of a larger ongoing qualitative study investi-
gating the best approaches to optimizing CPOE based on the
insights of key personnel within digitally mature hospitals in the
United Kingdom, mainland Europe, and the United States. The
methods employed are described in detail elsewhere,25 but the meth-
odology is described briefly subsequently.
Recruitment
Participants were healthcare professionals or informatics specialists
drawn from digitally mature sites (defined using the latest HIMSS
[Healthcare Information and Management Systems Society] Elec-
tronic Medical Record Adoption Model criteria as hospitals classi-
fied as level 6 or 7)26 that had been extensively involved in the
implementation and optimization of HITs such as EHRs, CPOE,
CDS, and telehealth. Sites were identified through 2 distinct strate-
gies. First, a scoping review of optimization strategies in electronic
prescribing was undertaken,27 with sites featuring prominently in
this literature contacted for participation. Second, drawing on a net-
work of experts in the field of electronic prescribing, potential sites
were discussed as candidates for recruitment at roundtable events.
Following the identification of 6 digitally mature sites, emails were
sent to key contacts (eg, pharmacy managers, or heads of research
departments) to request permission to contact members of staff
within the organization. Following this, a purposive sampling strat-
egy was used to recruit key member of staff who had been involved
in optimizing HIT within each site, with information and consent
forms communicated via email.
Data collection
Semi-structured interviews were used in this study, with interviews
conducted by 2 experienced qualitative researchers (C.H. and S.M.).
The interviews primarily focused on general approaches to optimiz-
ing CPOE. However, as the COVID-19 pandemic arose immediately
prior to commencement of data collection, questions regarding each
site’s response to the pandemic from an HIT standpoint were incor-
porated into the broader interview topic guide. Specifically, partici-
pants were asked whether any specific changes or strategies were
put in place within the EHR or related technologies as a direct re-
sponse to COVID-19. When asking questions relating to telehealth,
this was defined as any form of healthcare that was provided re-
motely to a patient. Follow-up questions were then asked based on
the participant’s responses to gain further insights. All interviews
were conducted via videoconferencing software. All interviews were
audio-recorded and transcribed verbatim. The full interview topic
guide can be viewed in Supplementary Appendix 1, with questions
5, 5.1, and 5.2 relating to this study.
Data analysis
Thematic analysis was undertaken on the dataset using an inductive
approach,28 which involved the coding of transcripts to identify
themes. In order to develop a coding framework, 2 researchers
(C.H. and S.M.) first independently coded 2 transcripts before dis-
cussing any discrepancies between code allocations in the text. The
framework was then applied to the remaining transcripts, before the
researchers collectively grouped codes into themes and subthemes.
In order to reduce the potential effects of researcher biases during
data collection and analysis, the researchers employed prospective
reflexivity when conducting the interviews and interpreting the find-
ings.29 Data analysis was conducted using NVivo 12 pro qualitative
data analysis software (QSR International, Burlington, MA).
Further details on data collection and analysis are available
elsewhere.25
Institutional review board approval
Ethical approval for this study was granted by the Usher Research
Ethics Group (University of Edinburgh) on January 1, 2020 (ref.
1906). Further details of ethical considerations of the study are de-
tailed elsewhere.25
RESULTS
Forty-four interviews were conducted across 6 sites (2 UK- and 4
U.S.-based sites) all of which were teaching hospitals affiliated with
academic institutions. A range of healthcare professionals, all with
expertise in medical informatics, participated in the interviews. In-
terviewee roles included pharmacy managers, pharmacists, nurses,
physicians, data analysts, and chief information officers. To ensure
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anonymity, job titles have been generalized alongside any accompa-
nying quotes in the results. Further details of each site are presented
in Table 1.
Thematic analysis identified 3 major themes and 6 subthemes,
detailed subsequently. Further quotes can be observed in Table 2.
Managing time and resources
One major theme discussed by all participants was the need to man-
age an unusually high number of patients, coupled with the addi-
tional strain the pandemic placed on resources such as medications,
ICU beds, and staff. This necessitated rapid and responsive organi-
zational and technological changes to health systems.
Expediting governance processes
The pandemic was viewed across study sites as impacting on the or-
dinary governance procedures involved when seeking to change
practices or alter HIT systems rapidly. This was viewed as largely
positive by those seeking to move existing paper-based practices to
digital, especially given the time and safety considerations raised by
the pandemic. Putting streamlined governance in place facilitated
timely implementations and optimizations of new HIT adaptations
related specifically to managing COVID-19.
We introduced a system whereby anything COVID related
moved up the list as it were, and there has been, sort of the [site]
set up the different sort of communications network to deal with
COVID. So, requests that come in around COVID could be
dealt with, you know, quicker than they would have done nor-
mally, so all that’s been done.
Site 2. Informatics lead (United Kingdom)
In the following excerpt, the interviewee is describing changes to
the system made in response to a government imperative to decrease
the burden of documentation prompted by COVID-19.
So, what we did was we took a look at the regulations and said,
okay, well we can make some changes within our system. Some
of it was just that we told people that they didn’t have to get the
patient to sign it any more. But then we were able to, you know,
make some simple changes within our system to designate areas
where nurses did need to document.
Site 4. Informatics nurse (United States)
It was apparent across study sites that in addition to streamlin-
ing governance procedures, informaticians were also given more
autonomy and leveraged to develop HIT solutions to the issues
created by COVID-19. For example, hospital management were
perceived to have taken more interest in the potential of EHRs
and the use of data to facilitate more efficient and targeted care
and make changes rapidly. Some participants stated that they felt
their work was more valued by management than before the pan-
demic.
With the current situation, we have had some of the attention
of those other people [hospital management] because it’s be-
come more of a management issue, which patient is going in
which ward is affected by their COVID status, that sort of
thing. And preventing, you know, people moving around the
hospital, getting data to do it automatically is more of a focus
for hospital management than it has been in the past. So, you
know, that’s a sort of positive thing that’s come out of it in a
way.
Site A. Informatician (United Kingdom)
Longer-term impact
A number of interviewees that acknowledged the rapid shifts both
to the CPOE system and in the behavior of users also questioned
what the longer-term impact of the pandemic would be.
But, you know, the comprehensiveness of the system is, you
know, basically all order comms, patient vital sign recording, yes,
nursing documentation, medical documentation. All that is on
the system now. And even, you know, COVID has accelerated
some change. I wonder how we will pull back or decide what to
keep when it’s all over.
Site 2. Pharmacy manager (United Kingdom)
Managing hospital beds
Participants highlighted that general and critical care beds were near
capacity during the first wave of the pandemic, and measures were
needed to control flow of patients between admission, ICU, and dis-
charge. One such example was the incorporation of discharge as-
sessment into the EHR system, which allowed discharging
physicians to complete the necessary patient checklists that would
ordinarily be completed separately by infection control; this signifi-
cantly reduced discharge times and, in turn, increased hospital bed
capacity.
To take someone off precautions, to be able to move them out of
their room or out of the hospital, we had to have infection con-
trol review their record. So I would have to pick up the phone
and say. . .and have a conversation, so even just that, we were
able to build a de-escalation order that had a series of yes, no
questions that we basically modelled on what the infection con-
trol person would have been asking. . . de-escalation orders usu-
ally took 12 hours to get done to like two hours, which has a big
impact on patient throughput. . .
Site 4. Physician A (United States)
Additionally, EHRs and related functionalities were deemed to
have been vital in managing the high number of patients and fore-
casting which wards would soon be reaching capacity. Improving in-
teroperability of different systems was an important step to
achieving this.
Identifying the appropriate infection control precautions for a
patient at the time of admission and then linking that to reports
around bed utilization so that we can much easier see how many
patients are in COVID precautions in the hospital, how many
patients are positive. And you can have really a window in terms
of your bed efficiency and blocked beds, if you need private
rooms for COVID positive patients. And so that really drove a
large system change around linking bed assignments, electronic
infrastructure for bed assignments, to orders for precautions, to
lab results.
Site 4. Physician B (United States)
Reducing medication shortages
Most participants acknowledged that the first wave of the pandemic
placed considerable strain on medication supplies, with providers
often ordering drugs that had not yet been shown to be effective in
treating COVID-19 patients, in turn leading to shortages of treat-
ments for other conditions. Once inappropriate prescribing patterns
were identified, 2 of the U.S. sites developed hard-stop alerts, which
prevented patients confirmed to be COVID-19 positive from being
prescribed certain drugs through the CPOE system, for example
tocilizumab.
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Table 2. Additional quotes for the themes and subthemes identified in the study
Theme/subtheme Quotes
Managing time and resources
Expediting governance processes For years we’ve been trying to do the [Take-home medications] process electronically and it’s met
with resistance from doctors and pharmacists. You know, they’re like, oh, it’ll never work, sort
of scenario. And so we had something almost ready to go that would fit and then with the
COVID it went in a week because everyone could see that sort of thing needed to be done.
Site1. Informatics nurse (United Kingdom)
It took only six. . .it took a matter of hours to implement something, a change to the system, when
it was very urgent related to patient care, but if it’s something that’s not as urgent it could take
much longer. Site 3. Pharmacist (United States)
Now that we’ve had COVID it works even better [governance process] because now we’ve had to
make so many changes so quickly. We had that structure originally and people were familiar
with each other already and now they trust each other a lot more. Site 5. Pharmacy manager
(United States)
So, we have some bright people who were given the charge to do something very quickly, they are
very bright people and, in fact, it did get done very quickly. As soon as they got that done, an-
other request came along to do something else, you know, and can you do that by next Wednes-
day, kind of a thing. Site 6.CDSmanager (United States)
Longer term impact I think it’s going to be really interesting to see what the new normal looks like, when the service is
back up and running. Clearly, it’s really important for us to speak to patients. We want to speak
to patients. But, yeah, there’s kind of no reason why people can’t be doing that in different
ways, and actually if we can get the Microsoft Teams bit working at the patient bedside, so ac-
tually you could speak to patients as well, and then in many ways we could start to deliver our
service in a hugely different way. Site 1. Pharmacist (United Kingdom)
Managing hospital beds For the discharge medication for a patient to go. . .whatever they’re going home on, it used to be pre-
scribed on probably two [prescribing software] on [EHR system] and then printed out by the doc-
tor and then sent down on a piece of paper down to pharmacy and they would dispense from that
piece of paper. So now it’s still done on [EHR system], a button is hit to say the patient’s ready to
go home and it’s printed off. It is still printed off in pharmacy but at least it’s there, rather than
having to go through the process. So that was. . .I mean, that’s quite a major change. Site 1. Infor-
matics nurse (United Kingdom)
There’s been plenty of impacts because of COVID. I think the main thing has been more about
identification, streaming of patients to the correct zones in the hospital, being able to quickly
identify and locate where said patients are, whether [they are], in fact, you know, probably or
confirmed [COVID-19]. Site 2. Physician (United Kingdom)
Reducing medication shortages What I’ve seen that’s been helpful to providers are these best practice alerts that come up that in-
form providers on things that come up like say for drug shortages or for recommendations for
the COVID that are, you know, kind of, acute things that help providers guide them into the
right thing saying, oh, we don’t have this medication, we’re switching over to this, so that these
types of alerts that keep people, kind of, up to date on what’s been recommended have been, I
think, helpful on that. Site 3. Pharmacist (United States)
Tocilizumab. . .so when this information was coming out quickly one thing they did do is they put
restrictions on who could order it to prevent, you know, rogue prescribing in the absence of
data. So that was like one of the things that they did as far as a quick thing that they could
make a change in the background and limit who was getting it. Site 3. Physician. (United
States)
Most of our alerts were around drug shortages and the different mitigation strategies on, and then
which drugs we were using because we were experiencing drug shortages so quickly that it was
almost every day we were building alerts or firing something different to guide providers. Site 5.
Pharmacy manager (United States)
Improving treatment accuracy
and effectiveness
if someone tries to prescribe Hydroxychloroquine, which has now shown that it’s not very evi-
dence based to use, they’ll get an alert that says, oh, we don’t use that here for COVID. We
just. . .it’s, you know, used only for rheumatologic or. . .so they’ve tried to optimise in terms of
some recommendations. Site 3. Pharmacist (United States)
So we were able to identify drugs that needed to be approved or not approved if the patient was
on COVID. So if I had a patient who was COVID positive, that BPA [best practice alert]
would fire when they would try to order anything nebulisation, Albuterol, inhaled Epoproste-
nol, and said, you will not be able to order this, please use the metered dose inhaler. So we built
a lot of decision support based on COVID-19 results, whether they’re anticoagulation, treat-
ment algorithms, I mean, really, they were. . .we did a lot, we worked daily on COVID updates.
Site 5. Pharmacy manager. (United States)
(continued)
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The best example I can tell you is tocilizumab, an IL-6 inhibitor
used all the time for rheumatoid disease and sometimes used for
other oncologic indications for cytokine storm not related to
COVID. But people were using it for COVID and we were start-
ing to have drug shortages and all kinds of other things. It was
like, we’ve got to block this from COVID ordering. So, if the pa-
tient was COVID positive and ordered tocilizumab it blocked
them but if they ordered tocilizumab for a patient who was not
COVID positive, [the system] allowed it to go through.
Site 3. Pharmacy manager (United States)
In the case that inappropriate ordering was undertaken, some
sites utilized order sets in combination with decision support to not
only advise on correct prescribing, but also point to alternatives to
the drugs prescribed if supply was limited.
We used order sets to at least flag labs and imaging quickly be-
cause everyone is learning all of it, and so we used admission or-
der sets and order sets a little bit more to drive people to at least
think about things. We were able to use decision support pro-
gramming to help with Remdesivir when it was still limited, to
drive indications and help identify the appropriate patients for its
use.
Site 4. Physician B (United States)
Improving treatment accuracy and effectiveness
Interoperability of systems and integration of data sources
Making all relevant information about a patient easily accessible
and viewable to providers was highlighted as important when
Table 2. continued
Theme/subtheme Quotes
Interoperability of systems and
integration of data sources
I’m working on, since the COVID situation, an oxygen report to try and look at oxygen usage
from a moment to moment basis, and we’re using a bit of [CPOE], bit of our critical care
[CPOE] system, a bit of our [CPOE] system to be able to pull that data together. We wouldn’t
have been able to do that not very long ago. Each new database that we get access to allows. . .is
another piece of the puzzle really, that allows us to bring those things together. Site 1. Analyst
(United Kingdom)
We were able to optimise this report and get it automatically run and emailed to our entire phar-
macist staff every 24 hours. So this is a way for the frontline pharmacists that are working in
the COVID ICUs, even some of the med surg units where we have, you know, some COVID
patients, they can see, hey this patient is blowing through Midazolam, to help us manage our
supply. Are there more clinical alerts we need to put? Do we need to put in any hard stops for
Midazolam? Site 3. Pharmacy manager (United States)
Negating infection risk in hospital They [neighboring hospital] haven’t got [CPOE]. So their level of service, has been so much
worse, and yet their pharmacy team has been more effected by COVID as in, you know, their
team contracting it, because they’re having to go to wards, whereas we’ve been able to not go
to wards, but still offer a much more robust service. Site 1. Pharmacist (United Kingdom)
Some patients don’t have their own devices or they’re so sick they can’t manage their own device
and so having the iPads deployed was phenomenal and we use that. Physicians used it to talk
with the families and then at end of life it was also a very good resource. Site 5. Informatician
(U.S)
Some things at the beginning when we were trying to socially distance, when people were working
from home and they’re self-isolating having an electronic system has been brilliant because they
can work from home. They’re socially isolating, they’re not unwell, so they can do a clinical job
from home. We had people sort of paired up so have one person at home and one person on the
floor so if they needed anything on site they were liaising. But that has really helped; it’s helped
with doctors for doing remote clinics, we’ve still been able to get prescriptions generated. Site
2. Pharmacy lead (United Kingdom)
I know there are a lot of different alerts that are firing that inform physicians, they inform practice
nurses of patients, for example, is either COVID positive or has not been tested and they have
to be tested or they are in quarantine until the result comes back. Site 6. Pharmacist (United
States)
Upscaling of telehealth usage
and capabilities
We’ve got a lot of people working from home, so when we were looking at our approach there we
quite deliberately, rather than bringing in a new home working remote access solution, we took
the solutions that we’d got and scaled them out. One of the benefits of that was. . .one of the
solutions is a virtual display approach, which we had because our particular clinical system
only worked that way. What that’s meant is that clinicians can actually also work at home. Site
1. Infromatics lead (United Kingdom)
So before COVID, yes, getting people to use the [patient] portal, oh, was like painful but we have
over 70 per cent and I’m sure it’s even higher now, people that are now using the portal so we
have seen a dramatic change with COVID. Site 5. Informatician (United States)
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treating a high number of patients with COVID-19 and other com-
plex morbidities. Examples of configuring provider computer
screens to allow this information to be viewed easily were provided
in 2 sites, and the capabilities of integrated EHR systems were
exploited to allow for the combining of data from multiple sources
such as labs and prescribing.
A snapshot screen that they’ve created for COVID where basi-
cally all of the relevant laboratory parameters and clinical infor-
mation you’d want to know about a COVID patient, are all
brought together in one screen which feature in [integrated EHR
system] a lot of specialities. You know, when it was needed in the
in-patient setting, I think, rather quickly and it was mentioned
by many clinicians to be very useful in the care of complex
COVID patients.
Site 3. Physician (United States)
Similarly, building patient information from multiple systems
into CDS messages in order to identify patients who may require a
higher level of care was also undertaken within numerous sites. This
was viewed as a way of facilitating timely, targeted treatment for
patients who may need further surveillance for complications.
With acute kidney injury, when patients come in, we pull data
from the pathology labs, we pull data from prescribing, and we
can flag to our pharmacists, actually, this patient’s at really high
risk of acute kidney injury, and we’re doing that with COVID
patients now, that are coming in, ’cause we know that they are
susceptible to renal failure, so you know, we can start to flag
those patients nice and early.
Site 1. Pharmacy manager (United Kingdom)
Negating infection risk in hospital
Across all study sites, EHRs and related technologies played a major
role in identifying COVID-19–positive patients, coordinating isola-
tion units, and minimizing infection risk to both providers and
patients being treated for other conditions. For example, after re-
ceiving a positive test result, or displaying COVID-related symp-
toms, changes were made to provider display screens to clearly
indicate when a patient had been confirmed or was suspected to
have COVID-19.
A big thing that we were involved with was how to alert our pro-
viders that a patient is COVID-19 positive. We. . .have a blue
banner that changes. So, it’s like the header, top of the screen. . .it
has a lot of patient information. Height, weight, allergies infor-
mation. It turns blue if a patient is suspected COVID or COVID
positive.
Site 5. Pharmacy manager (United States)
The need to ensure patients were being placed in the correct part
of the hospital and to keep track of patients within the hospital has
proven to be an important functionality of the EHR system.
Yeah, there’s been plenty of impacts because of COVID. I think
the main thing has been more about identification, streaming of
patients to the correct zones in the hospital, being able to quickly
identify and locate where said patients are, whether their status
is, in fact, probably or confirmed.
Site 2. Physician (United Kingdom)
Upscaling of telehealth usage and capabilities
Moving routine and nonessential outpatient appointments to tele-
health (either via phone call, video conferencing, or existing patient
portals) was undertaken to some degree within all 6 of the partici-
pating sites, and this was highlighted as an integral aspect of reduc-
ing risk of infection to both patients and providers.
Like tele-medicine, through the patient portal, before COVID
we were doing about 30 tele-medicine visits a week, and now
we’re over 4,000 a day. Our adoption. . .of a patient portal, it
went from 30 per cent to about 75 percent. COVID has, you
know, completely changed things.
Site 5. infromatics lead (United States)
Similarly, using technology to facilitate minimal-contact ward
rounds within hospital was implemented in multiple sites, which re-
duced the need to use personal protective equipment (PPE), and mit-
igated risk of infection to providers.
We put monitors in rooms so that I could actually contact the pa-
tient, see the patient from outside their room so we didn’t have to
use so much PPE going in and out of rooms so that way, kind of
consolidating how many times I went into a patient’s room. So
we had those set up in our intensive care units and in our. . .in
what we designated as our infection or COVID units.
Site 5. Informatics manager (United States)
Such capabilities were also extended to allow many routine pro-
cedures such as medication reconciliation and patient chart updates
to be conducted remotely, often outside the hospital campuses via
secure remote-working systems. This was viewed as an important
aspect of risk de-escalation for providers who would otherwise need
to enter wards to conduct such tasks. Additionally, staff who were
required to self-isolate due to a positive close contact could still pro-
vide support remotely by conducting medication reconciliation or
administration from home.
During this pandemic, it’s been really useful, because we’ve been
able to, even when staff are self-isolating, they can still cover a
ward remotely, ‘cause we can remote into the summary care re-
cord, we can remote into their prescribing record, and all the
other systems, so we’ve been covering lots of the hospital, doing
all the medicines reconciliation, all that kind of stuff remotely
from home.
Site 1. Pharmacy manager (United Kingdom)
DISCUSSION
We assessed HIT-dependent approaches used to treat patients, man-
age resources, and mitigate in-hospital infection risk during the
COVID-19 pandemic within 6 digitally mature international sites.
All participating sites acted quickly in altering governance and nor-
mal procedural practices to allow rapid changes to be made to EHR
systems and accompanying technologies. Changes to such organiza-
tional factors have been highlighted in the literature as integral to
responding to the pandemic.14 Additionally, making changes to in-
crease interoperability of systems, ease of access to and presentation
of relevant patient data, and upscaling of telehealth usage were all
adaptations viewed as facilitating more effective practice in the pre-
sent study. Importantly, the HIT-related responses to COVID-19
were perceived to have further highlighted the value of informati-
cians for improving care and responding quickly to emergent needs.
The optimization and addition of new alerts were utilized both
to improve treatment effectiveness and to reduce drug shortages ex-
perienced due to incorrect prescribing by introducing hard-stop
alerts in combination with decision support and order sets, directing
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prescribers to more appropriate medications. Similar strategies have
been employed to decrease drug shortages prior to the COVID-19
outbreak. For example, Brokenshire et al30 tested a combination of
hard- and soft-stop alerts to address opioid shortages. As expected,
the study found hard stops to be more effective at reducing opioid
ordering with immediate effect, while soft stops led to more subtle
decreases in medication ordering over time or had no effect. While
the use of hard-stop alerts must be carefully considered in routine
medical care,31 their ability to abruptly stop inappropriate ordering
of scarce medications may be of most benefit during pandemic situa-
tions in which the strain on resources is unprecedented, as demon-
strated by their adoption in this present study.
Another healthcare resource that participating sites used HIT to
manage was hospital beds, both through the building of discharge
procedures into the EHR and ensuring appropriate integration of
systems and data sources to allow bed capacity to be managed in
real time. Both these strategies have also been described in the litera-
ture regarding responses to COVID-19.32 Additionally, other inno-
vative technological approaches to ensuring patient flow and bed
availability are evident in the literature. One study aimed to decrease
the burden of occupied beds by fitting wearable devices to 40
patients at discharge to monitor vital signs.21 While many patients
required home oxygen orders, none were rehospitalized in this
study. Such initiatives, coupled with streamlined EHR-based dis-
charge assessment and increased system integration, have helped
make available badly needed hospital beds.
In addition, HIT was used not only to treat COVID-19 patients
and manage the direct burden on resources, but also to mitigate the
risks of infections occurring within hospital. Telehealth was utilized
to some extent in all sites, with hospitals that already had some
form of patient portal upscaling the use of such technologies. In
many places, this was dramatic, with near-overnight adoption of tel-
ehealth at a scale not previously considered. The potential for tele-
health to protect both routine patients and healthcare personnel
from infection is highlighted by Russi et al.33 Additionally, the rapid
implementation of a patient self-triage tool within a EHR patient
portal was effective at reducing nonurgent triage times and in-
person contacts, and had 88% sensitivity for detecting emergency-
level patients.34
The present study resonates with the literature in highlighting
the use of mobile devices and screens to limit face-to-face contact be-
tween healthcare staff and confirmed COVID-19 patients as part of
telehealth provision. The use of bedside tablets in isolation units and
remote medication reconciliation procedures in the present study
were both considered important interventions in reducing risk of in-
fection amongst participants. Similarly, Lin et al14 utilized tablets at
patient’s bedsides for physical examinations, remote familial visits,
and non–COVID-19–related care such as newborn-family interac-
tions and remote group therapy sessions. Grange et al22 also de-
scribed the use of a cart-mounted camera and screen used to
monitor ICU patients with COVID-19, which allowed specialists to
see patients remotely, and removed the need to don PPE, which is
both time-consuming and costly. However, such technologies must
be adequately integrated with the relevant existing systems and pa-
tient data sources if an optimized outcome for care is to be ensured.
Furthermore, isolating patients can both be difficult psychologically
and may also increase their safety risks.35
This study has several limitations that should be considered
when interpreting the findings. First, we present early qualitative
findings without accompanying outcome evaluations of the techno-
logical changes described by the participants in this study. It is there-
fore not possible to draw definite conclusions regarding the
effectiveness of these interventions, and formal evaluations should
be undertaken to determine efficacy. Second, this article presents
findings obtained from interviews that were primarily designed to
investigate the wider optimizations of CPOE systems at the partici-
pating sites,25 rather than specific optimizations due to COVID-19,
meaning that the data obtained may not fully capture the full extent
of the adaptations undertaken. Despite this, the present study in-
cluded perspectives from over 40 experts in medical informatics and
patient safety within digitally mature sites, who were all directly in-
volved in the technological adaptations described to some extent.
Furthermore, while similar studies have previously been published
investigating the use of HIT to respond to COVID-
19,15,17,18,21,22,32,34 these studies are largely small-scale, single-cen-
ter studies. In contrast, this study presents data from 6 digitally ma-
ture sites both in the United States and in the United Kingdom,
offering further lessons of the role that informatics can play in com-
bating COVID-19 across differing healthcare contexts. The present
study also further highlights the value of informaticians, not only in
how they can contribute to optimal routine patient care, but also in
how they can rapidly configure and implement relevant HITs in
acute situations such as the COVID-19 pandemic.
CONCLUSION
This study presents the views and experiences of key experts in pa-
tient safety and medical informatics who have worked to improve
their site’s respective EHR systems during the COVID-19 pandemic.
As might be expected, many systems made substantial and rapid
changes to adapt that were facilitated by streamlined governance
and the leveraging of informaticians to improve systems. Key points
identified include the utility of existing EHR systems in supporting
rapid expansion of telehealth, the importance of interoperability
and availability of patient data to the provider, and strategies for
conserving resources. Although some of these lessons may already
have been learned and adopted within digitally mature hospitals,
this article can indicate potential strategies for less digitally mature
settings, and for responses to future pandemics of a similar nature.
Our interview data point to the value of a combination of responsive
governance, EHRs, and accompanying technologies to reduce bur-
den of care and decrease discharge time, drug shortages, and health
worker exposure. As COVID-19 continues to be at the forefront of
global healthcare priorities, more health systems can begin to con-
sider how best to utilize HIT in the fight against the disease.
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